Anoikis molecular pathways and its role in cancer progression

• Published in: Biochimica et biophysica acta 2013-12, Vol.1833 (12), p.3481-3498
• Main Authors: Paoli, Paolo, Giannoni, Elisa, Chiarugi, Paola
• Format: Article
• Language: English
• Subjects: Animals; Anoikis; Cancer; Cytoprotection; Disease Progression; Humans; Metabolism; MicroRNA; Neoplasm Metastasis; Neoplasms - pathology; Reactive oxygen species; Signal Transduction
• ISSN: 0167-4889; 0006-3002; 1879-2596
• DOI: 10.1016/j.bbamcr.2013.06.026

Anoikis is a programmed cell death induced upon cell detachment from extracellular matrix, behaving as a critical mechanism in preventing adherent-independent cell growth and attachment to an inappropriate matrix, thus avoiding colonizing of distant organs. As anchorage-independent growth and epithelial–mesenchymal transition, two features associated with anoikis resistance, are vital steps during cancer progression and metastatic colonization, the ability of cancer cells to resist anoikis has now attracted main attention from the scientific community. Cancer cells develop anoikis resistance due to several mechanisms, including change in integrins' repertoire allowing them to grow in different niches, activation of a plethora of inside-out pro-survival signals as over-activation of receptors due to sustained autocrine loops, oncogene activation, growth factor receptor overexpression, or mutation/upregulation of key enzymes involved in integrin or growth factor receptor signaling. In addition, tumor microenvironment has also been acknowledged to contribute to anoikis resistance of bystander cancer cells, by modulating matrix stiffness, enhancing oxidative stress, producing pro-survival soluble factors, triggering epithelial–mesenchymal transition and self-renewal ability, as well as leading to metabolic deregulations of cancer cells. All these events help cancer cells to inhibit the apoptosis machinery and sustain pro-survival signals after detachment, counteracting anoikis and constituting promising targets for anti-metastatic pharmacological therapy. This article is part of a Special Section entitled: Cell Death Pathways. Guest Editors: Frank Madeo and Slaven Stekovic. •Anoikis is a hallmark of cancer enabling tumor cells with metastatic skills.•Cancer cells exploit different strategies to overcome anoikis.•miRNA modulation and metabolic adaptation correlate with anoikis resistance.•Oxidative stress and hypoxia favor cell escaping from anoikis.•Anoikis insensitivity provides several advantages alongside the metastatic pathway.